- EnteroMedics Reports Q4 2011 Results;Gets Final Australian Approval - January 26, 2012
- Epizyme Achieves $4M Milestone Payment in Esai Partnership - January 10, 2012
- IDEV Technologies Announces Publication of Stent Data - December 15, 2011
- EnteroMedics Receives Approval of AIMD Components in Australia - December 13, 2011
- PTC Therapeutics Signs Agreement with Roche - November 29, 2011
- GenturaDx Announces Formation of Scientific Advisory Board - November 22, 2011
- Poniard Pharmaceuticals Licenses Its Focal Adhesion Kinase Technology - November 18, 2011
- IDEV Technologies Gets FDA Clearance for 6 Fr Stent Delivery System - November 10, 2011
- PTC Therapeutics Receives Grand Challenges Explorations Funding - November 7, 2011
- Presidio Pharmaceuticals Announces Clinical Proof-of-Concept - November 4, 2011
- Epizyme Achieves Pre-Clinical Milestone Payments in GSK Alliance - October 14, 2011
- Merus Launches MeMo™ For Improved Therapeutic Human mAbs - September 27, 2011
- Aragon Surgical Assets Acquired by Aesculap - September 27, 2011
- Calypso Medical Technologies Acquired by Varian Medical Systems - September 19, 2011
- Epizyme, Inc. Named a “Fierce 15” Biotech Company for 2011 - September 6, 2011
- MAP Pharmaceuticals Issued U.S. Patent For LEVADEX® - August 11, 2011
- Sunesis Pharmaceuticals Issued U.S. Patent Covering Vosaroxin for Leukemia - August 3, 2011
- Aciex Therapeutics Signs Agreement with Akorn, Inc. - August 2, 2011
- MAP Pharmaceuticals Announces FDA Acceptance for Filing of NDA for LEVADEX® - August 2, 2011
- Nevro Closes $58M in New Financing - July 19, 2011
- IDEV Launches Lower Profile SUPERA VERITAS® Stent Delivery System - July 12, 2011
- Epizyme and Collaborators Publish Breakthrough Research in Cancer Treatment - July 11, 2011
- Epizyme and The Leukemia & Lymphoma Society Partner for Drug Development - June 23, 2011
- VIA Pharmaceuticals Announces Human Dosing of VIA-3196 in Phase 1 Trial - June 13, 2011
- Cadence Pharmaceuticals Announces Addition of OFIRMEV® to Military's JDF - June 7, 2011
- IDEV Technologies Announces Completion of SUPERB Clinical Trial Enrollment - June 2, 2011
- MAP Pharmaceuticals Submits NDA for LEVADEX® Orally Inhaled Migraine Drug - May 26, 2011
- EnteroMedics Announces First Implant in ReCharge Pivotal Trial for Obesity - May 18, 2011
- IDEV Reports SUPERA® Stent Efficacy in SFA and Popliteal Arteries - May 17, 2011
- Merus Receives Grant for Breast Cancer Antibody Therapy - May 16, 2011
- GenturaDx Announces Completion of Alpha Study, Beta Studies on Track - May 16, 2011
- Cadence Pharmaceuticals Reports First Quarter 2011 Financial Results - May 5, 2011
- IDEV Announces Full Canadian Regulatory Approval for SUPERA VERITAS® - April 14, 2011
- Conatus Pharmaceuticals Completes the Second Closing of Series B Financing - April 12, 2011
- Aviir Launches Unique Cardiac Clinical Laboratory in Southern California - April 5, 2011
- Sunesis Pharmaceuticals and Millennium Pharmaceuticals Announce Collaboration - April 5, 2011
- EnteroMedics Receives CE Mark Approval of Maestro(r) RC System -March 28, 2011
- Nevro Appoints Michael DeMane President and Chief Executive Officer - March 17, 2011
- Epizyme Enters Worldwide Strategic Partnership with Eisai - March 10, 2011
- Sunesis Issued European Patent Covering Vosaroxin Clinical Formulation - March 10, 2011
- Poniard Pharmaceuticals Receives Approval in China for Picoplatin Development - March 3, 2011
- Poniard Pharmaceuticals Completes $1.9M Financing - February 9, 2011
- IDEV Technologies Reports Positive Results for SUPERA Stent - February 8, 2011
- Epocrates, Inc. Announces Pricing of Initial Public Offering - February 2, 2011
- MAP Pharmaceuticals and Allergan Announce Collaboration - January 31, 2011
- Cadence Pharmaceuticals Launches OFIRMEV In the U.S. - January 18, 2011
- Calypso Medical Completes First Installation of Dyamic Edge Gating -January 13,2011
- NextWave Pharmaceuticals Secures $45M in Financing - January 11, 2011
- Epizyme Announces Strategic Alliance with GlaxoSmithKline - January 10, 2011
